[(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate

C47H82O9 — CID 54764099

IUPAC[(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate
SMILESCCCCCCCCCCCCCC(=O)OC[C@H]1O[C@H](O[C@H]2CC[C@@]3(C)C(=C(O)C(O)[C@H]4[C@@H]5CC[C@H]([C@H](C)CCCC(C)C)[C@@]5(C)CC[C@@H]43)C2)[C@@H](O)[C@@H](O)[C@H]1O
InChIInChI=1S/C47H82O9/c1-7-8-9-10-11-12-13-14-15-16-17-21-38(48)54-29-37-41(50)43(52)44(53)45(56-37)55-32-24-26-47(6)35-25-27-46(5)33(31(4)20-18-19-30(2)3)22-23-34(46)39(35)42(51)40(49)36(47)28-32/h30-35,37,39,41-45,49-53H,7-29H2,1-6H3/t31-,32+,33-,34+,35+,37-,39+,41+,42?,43+,44+,45+,46-,47-/m1/s1
InChIKeyZKOPVLDZVZHKAQ-INDDRUFRSA-N
MW791.16 g/mol
LogP9.32
Rot. Bonds21

About [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate

[(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate (PubChem CID 54764099) has the molecular formula C47H82O9 and a molecular weight of 791.16 g/mol. Its IUPAC name is [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate.

Molecular Properties

Compound Name[(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate
PubChem CID54764099
Molecular FormulaC47H82O9
Molecular Weight791.16 g/mol
Exact Mass790.60
IUPAC Name[(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate
SMILESCCCCCCCCCCCCCC(=O)OC[C@H]1O[C@H](O[C@H]2CC[C@@]3(C)C(=C(O)C(O)[C@H]4[C@@H]5CC[C@H]([C@H](C)CCCC(C)C)[C@@]5(C)CC[C@@H]43)C2)[C@@H](O)[C@@H](O)[C@H]1O
InChIInChI=1S/C47H82O9/c1-7-8-9-10-11-12-13-14-15-16-17-21-38(48)54-29-37-41(50)43(52)44(53)45(56-37)55-32-24-26-47(6)35-25-27-46(5)33(31(4)20-18-19-30(2)3)22-23-34(46)39(35)42(51)40(49)36(47)28-32/h30-35,37,39,41-45,49-53H,7-29H2,1-6H3/t31-,32+,33-,34+,35+,37-,39+,41+,42?,43+,44+,45+,46-,47-/m1/s1
InChIKeyZKOPVLDZVZHKAQ-INDDRUFRSA-N
XLogP9.32
TPSA145.91 Ų
H-Bond Donors5
H-Bond Acceptors9
Rotatable Bonds21
Heavy Atoms56
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500791.16
LogP ≤ 59.32
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate?
The IUPAC name of [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate (CID 54764099) is [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate.
What is the SMILES notation for [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate?
The canonical SMILES for [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate is CCCCCCCCCCCCCC(=O)OC[C@H]1O[C@H](O[C@H]2CC[C@@]3(C)C(=C(O)C(O)[C@H]4[C@@H]5CC[C@H]([C@H](C)CCCC(C)C)[C@@]5(C)CC[C@@H]43)C2)[C@@H](O)[C@@H](O)[C@H]1O.
What is the InChIKey of [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate?
The InChIKey is ZKOPVLDZVZHKAQ-INDDRUFRSA-N. The full InChI is InChI=1S/C47H82O9/c1-7-8-9-10-11-12-13-14-15-16-17-21-38(48)54-29-37-41(50)43(52)44(53)45(56-37)55-32-24-26-47(6)35-25-27-46(5)33(31(4)20-18-19-30(2)3)22-23-34(46)39(35)42(51)40(49)36(47)28-32/h30-35,37,39,41-45,49-53H,7-29H2,1-6H3/t31-,32+,33-,34+,35+,37-,39+,41+,42?,43+,44+,45+,46-,47-/m1/s1.
What are the key properties of [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate?
[(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate has a molecular weight of 791.16 g/mol, XLogP of 9.32, 21 rotatable bonds, 5 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4S,5S,6S)-6-[[(3S,8S,9S,10R,13R,14S,17R)-6,7-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl tetradecanoate is sourced from PubChem (CID 54764099), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).